InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Thursday, 02/20/2014 12:03:50 AM

Thursday, February 20, 2014 12:03:50 AM

Post# of 346050

GlaxoSmithKline, Dr Reddy's to register first product in European Union this year

Feb 19, 2014


GlaxoSmithKline (GSK), in partnership with Dr Reddy's Laboratories (DRL), has planned to register their first product in the European Union during this calendar year.

He refused to name the product or its therapeutic segment.

Under the terms of the agreement of the deal, GSK will gain access to Dr Reddy’s diverse portfolio and future pipeline of more than 100 branded generics.As per the agreement, products will be co-marketed by Dr Reddy’s and GSK in certain markets.

http://www.financialexpress.com/news/glaxosmithkline-dr-reddys-to-register-first-product-in-european-union-this-year/1227287



--------------------------------------------------------------

No.... nah..... I will not even think of it till its confirmed, but hey, all the Dr. Reddy talk and GSK talk just ... well, I'll just wait till Steve King gives us more clues. : )

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News